Who owns Alpine Immune Sciences?

Top Holders and Investors of Alpine Immune Sciences Stock

Find out who owns Alpine Immune Sciences, who bought Alpine Immune Sciences this quarter, and who sold Alpine Immune Sciences?

Fund or Company Name Number of Shares Valued At As Of
OrbiMed Advisors 3.67M $14.10M Dec 2019
Frazier Management 2.57M $9.87M Dec 2019
Bvf 1.14M $4.37M Dec 2019
Deerfield Management Company 248992 $956129 Dec 2019
Vanguard 187043 $718245 Dec 2019
Hikari Power 185287 $711502 Dec 2019
Tiger Management 137728 $528875 Dec 2019
Renaissance Technologies 127810 $490790 Dec 2019
Dimensional Fund Advisors 45997 $177088 Dec 2019
Geode Capital Management 37436 $143005 Dec 2019
BlackRock 24081 $97768 Dec 2019
Alpine Woods Capital Investors 10580 $41050 Dec 2019
Northern Trust 10188 $39020 Dec 2019
Leonard Rickey Investment Advisors P 10000 $38000 Dec 2019
DRW Holdings 10000 $38000 Dec 2019
Ikarian Capital 4739 $18008 Dec 2019
Deutsche Bank Aktiengesellschaft 1065 $4004 Dec 2019
Royal Bank of Canada 251 $0 Dec 2019
Morgan Stanley 21 $0 Dec 2019

Who sold Alpine Immune Sciences?

Fund Name Date Sold Shares Held Valued At
Victory Capital Management Sep 2019 132603 $519803
Bank of America Corporation Sep 2019 366 $999
Tower Research Capital Sep 2019 89 $0
Barclays Sep 2019 2 $0